Select Page

PUTTING HEALTH FIRST

A new pharmaceuticals incentives agenda for the EU

Incentives for pharmaceutical innovation available in EU legislative instruments are up for review following the Council conclusions on strengthening the balance in the pharmaceutical systems in the EU and its Member States of 17 June 2016.

As a contribution to this review, EPHA hosts Medicines Law & Policy experts to launch a set of recommendations to improve the effectiveness of data exclusivity, the supplementary protection certificate and the orphan drug regulation in Europe. Medicines Law & Policy’s recommendations aim to introduce a better balanced incentive structure in the EU, to ensure new medicines are developed and become available at affordable prices.

 

AGENDA AVAILABLE SOON

Logistics

Where

The Office
Rue d’Arlon 80, 1040 Bruxelles

When

3 June 2019
10.30 – 12.30

PUTTING HEALTH FIRST

A new pharmaceuticals incentives agenda for the EU

© 2019 - Development by Simpl.

SUBSCRIBE TO OUR MAILING LIST

We publish our newsletter ten times a year to keep you informed about the latest news on public health in Europe. You can receive it directly in your mailbox.
First Name
Last Name
Email address
Secure and Spam free...